sotigalimab
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for sotigalimab, covering 2023-12-22 to 2023-12-22. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate Sotigalimab (APX005M) in Subjects With Unresectable or Metastatic Melanoma [Phase 2]